Leishmania (Viannia) lainsoni: First Isolation in Peru

Lucas, Carmen; Franke, Eileen D.; Cachay, Marlene I.; Tejada, Abelardo; Carrizales, D; Kreutzer, Richard D.

doi:10.4269/ajtmh.1994.51.533

Cited by 25 publications

(22 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition to Suriname, L. (V.) naiffi was identified as a cause of CL in particularly Amazonian Brazil [25,29,188,203,206] as well as various other Latin American and Caribbean countries [25,35,99,188,[205][206][207][208]. These observations suggest that L. (V.) naiffi is widespread in South America [99], which is consistent with the presence of both hosts and vectors in a wide geographical area in this continent [25].…”

Section: (V) Naiffisupporting

confidence: 64%

“…These observations suggest that L. (V.) naiffi is widespread in South America [99], which is consistent with the presence of both hosts and vectors in a wide geographical area in this continent [25]. Nevertheless, as reported for other endemic parts of South America and the Caribbean [25,29,35,188,203,[205][206][207][208], L. (V.) naiffi also seems an uncommon cause of CL in Suriname when compared to CL caused by other Leishmania species [164].…”

Section: (V) Naiffisupporting

confidence: 55%

“…After its original identification in samples from infected humans in the state of Pará in the Brazilian Amazon region [187], L. (V.) lainsoni was detected in CL patients from other parts of Brazil [188], the sub Andean regions of Peru [189] and Bolivia [190,191], French Guiana [35], and the Ecuadorian Amazon [192] besides Suriname [159].…”

Section: Still L (V) Lainsoni Is Probably Widely Distributed In Southmentioning

confidence: 99%

See 2 more Smart Citations

Epidemiological, Biological and Clinical Aspects of Leishmaniasis with Special Emphasis on Busi Yasi in Suriname

Mans¹,

Kent²,

Hu³

et al. 2017

J Clin Exp Dermatol Res

View full text Add to dashboard Cite

The parasitic disease leishmaniasis is caused by protozoa of the genus Leishmania which are transmitted by sand fly vectors of the genus Phlebotomus in the Old World and Lutzomyia in the New World. Transmission can either be anthroponotic (human to human) or zoonotic through mammalian reservoirs such as dogs and rodents. Leishmaniasis has three principal clinical manifestations, namely cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and visceral leishmaniasis (VL). The cutaneous form characteristically causes skin ulcers, the mucocutaneous form manifests as lesions of skin, mouth, and nose, and the (potentially lethal) visceral form affects the internal organs such as spleen and liver and also invades the bone marrow. Leishmaniasis is endemic in about ninety-eight countries and the diverse types of the disease occur in different regions of the world. CL is most common in Afghanistan, Algeria, Pakistan, Iran, Brazil, and Colombia; MCL is mainly restricted to countries of the Amazon Basin; and VL is most frequently seen in the Indian sub-continent, the Horn of Africa (Sudan and Ethiopia), and Brazil. The current global prevalence is estimated at about 12 million, and each year, the disease in one of its forms makes about 2 million new victims and claims up to 50,000 fatalities. This paper presents epidemiological, biological, and clinical aspects of leishmaniasis throughout the world; then focuses on the disease in the Republic of Suriname (South America); addresses in more detail the species of Leishmania parasites in that country; and concludes with potential future directions to improve our understanding of leishmaniasis in Suriname.

show abstract

Section: (V) Naiffisupporting

confidence: 64%

Section: (V) Naiffisupporting

confidence: 55%

Section: Still L (V) Lainsoni Is Probably Widely Distributed In Southmentioning

confidence: 99%

See 1 more Smart Citation

Epidemiological, Biological and Clinical Aspects of Leishmaniasis with Special Emphasis on Busi Yasi in Suriname

Mans¹,

Kent²,

Hu³

et al. 2017

J Clin Exp Dermatol Res

View full text Add to dashboard Cite

show abstract

“…[27][28][29] Thus, this case adds to the scientific literature regarding the epidemiology of this protozoan parasite.…”

Section: Discussionmentioning

confidence: 99%

“…Leishmania (V.) lainsoni is known to exist in the Brazilian Amazon region, 27 the Department of La Paz, Bolivia, 28 and the sub-Andean or high jungle regions of Peru. 1,29 Although the preferred vector of L. (V.) lainsoni, Lutzomyia ubiquitalis, has been found in Madre de Dios, 27 this report is the first documented case of probable human infection occurring from this region. In their study of the geographic distribution of leishmaniasis in Peru based on 350 clinical samples from patients in 15 Peruvian departments, Lucas and others isolated L. (V.) lainsoni from seven patients in high jungle regions.…”

Section: Discussionmentioning

confidence: 99%